specialistcannabinoids
University Specialist Course in the Use of Cannabis and Cannabinoid Derivatives
PRESENTATION
OBJECTIVES
The main objective of this University Specialist Degree in Cannabis and Cannabinoid Derivatives is to provide unequivocal, clear and contrasted information from an academic and scientific point of view about cannabis, natural and synthetic cannabinoid derivatives, and the endogenous cannabinoid system that can be useful for a wide range of professionals in both public centres and private companies with an interest in cannabinoids.
This idea can be summarised in the following specific objectives:
- To train specialists in academic, educational centres of public and private organisations capable of transmitting truthful and contrasted information on cannabis and cannabinoid derivatives.
- To train specialists who can initiate or extend scientific research of national and international interest in public and private research centres on a wide range of aspects related to cannabinoids.
- To train clinical specialists from different medical and pharmaceutical specialties in the approved, clinically tested and potentially useful therapeutic properties of natural and synthetic cannabinoids and endogenous ligand modulating drugs in order to be able to make therapeutic decisions based on proven scientific evidence.
- To train patent experts in the information necessary to acquire sufficient knowledge to regulate or reject cannabinoid products that are submitted by pharmaceutical companies for evaluation and subsequent sale on the national and international market.
COURSE DETAILS
Section 0. Introduction
Introduction. Cannabis: therapeutic or recreational drug
Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Section 1. Botany, pharmacognosy, pharmacology and recreational use of the cannabis plant
Lecture 1.1. History of cannabis, from its origins to today’s products
Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hernández, Spain
Lecture 1.2. Taxonomy and botany of cannabis. Macroscopic and microscopic characteristics
Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hernández, Spain
Lecture 1.3. Phytochemistry of cannabis: main families of compounds and their main pharmacological uses
Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hernández, Spain
Lecture 1.4. Main analytical techniques for the characterization of cannabis compounds. Good Laboratory Practices (GLP)
Prof. Enrique Barrajón Catalán, Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández, Spain
Lecture 1.5. Techniques for the extraction of active compounds from cannabis
Prof. Enrique Barrajón Catalán, Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández, Spain
Lecture 1.6. Pharmacology of cannabinoids (endogenous ligands, receptors, synthesis and degradation enzymes)
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 1.7. Cannabinoid signaling in the brain: extracting specificity from ubiquity
Prof. Giovanni Marsicano, NeuroCentre Magendie INSERM, University of Bordeaux, France
Section 2. Alterations of the cannabinoid system in animal experimentation and clinical pathology
Lecture 2.1. Endocannabinoid System Components as potential biomarkers
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.2. Immunohistochemistry, conventional and confocal microscopy, western blots (localization, antibodies, dimerization, colocalization, etc.)
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.3. Methodology for detecting changes in ECS components: gene expression, polymorphisms and epigenetics.
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.4. Methodology for detecting changes in ECS components: biochemistry
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.5. Methods for detecting changes in the endocannabinoid system: neuroimaging (PET, SPECT, fMRI)
Prof. Silvia de Santis, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.6. Alterations of the endocannabinoid system in gastrointestinal diseases
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.7. Alterations of the endocannabinoid system in liver diseases
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.8. Alterations of the endocannabinoid system in renal diseases
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.9. Alterations of the endocannabinoid system in endocrinology
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.10. Alterations of the endocannabinoid system in respiratory diseases
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.11. Alterations of the endocannabinoid system in oncology
Prof. Ana Lucía Yuste, Oncology Department, General Hospital of Alicante, Spain
Lecture 2.12. Changes in the endocannabinoid system in pain and inflammation
Prof. Katarzyna Starowicz, Maj Institute of Pharmacology Polish Academy of Sciences, Poland
Lecture 2.13. Alterations of the endocannabinoid system in neurology
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.14. Alterations of the endocannabinoid system in psychiatry
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Section 3. Therapeutic uses of cannabinoid derivatives I (pain, neurology and psychiatry)
Lecture 3.1. Therapeutic applications of cannabinoids in pain management
Prof. Raquel Saldaña, Anaesthesia Section at Hospital 12 De Octubre, Spain
Lecture 3.2. Therapeutic applications of cannabinoids in the management of neuropathic pain
Prof. Katarzyna Starowicz. Maj Institute of Pharmacology Polish Academy of Sciences, Poland
Lecture 3.3. Cannabinoid therapy in epilepsy and epileptic syndromes
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.4. Multiple sclerosis: role of cannabinoids in treatment and pathophysiological aspects
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.5. Cannabinoids and extrapyramidal pathology: Parkinson’s disease and other extrapyramidal diseases (dystonia, Gilles Tourette syndrome, tics, etc.).
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.6. Role of cannabinoids in migraine
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.7. Therapeutic usefulness of cannabinoids in anxiety and depressive disorders
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.8. Role of cannabinoid CB2 receptor in the regulation of emotional and addictive behaviors
Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.9. Role of cannabidiol and sertraline in regulating behavioral and brain gene expression changes in a novel animal model of posttraumatic stress disorder
Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.10. Role of cannabidiol in drug dependence
Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Section 4. Therapeutic uses of cannabinoid derivatives II (oncology, endocrinology, cardiology, respiratory, digestive, ophthalmology, dermatology, skeletal system, others)
Lecture 4.1. Regulation of the immune system by cannabinoids: inflammation and infection
Prof. Esther Caparrós Cayuela, Deparment Clinical Medicine, Universidad Miguel Hernández, Spain
Lecture 4.2. Cannabinoid products as immunomodulators: clinical trials and animal modeling
Prof. Esther Caparrós Cayuela, Deparment Clinical Medicine, Universidad Miguel Hernández, Spain
Lecture 4.3. Cannabinoid system-intestinal microbiome relationship: physiology and pathology
Prof. Esther Caparrós Cayuela, Deparment Clinical Medicine, Universidad Miguel Hernández, Spain
Lecture 4.4. Utility of cannabinoid therapy in cardiovascular pathology
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.5. Role of the endocannabinoid system in energy balance and obesity
Prof. Daniela Cota, NeuroCentre Magendie INSERM, University of Bordeaux, France
Lecture 4.6. Therapeutic potential of the use of cannabinoid compounds in the treatment of renal pathologies
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.7. Potential therapeutic utility of cannabinoid compounds in liver diseases
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.8. Potential therapeutic utility of cannabinoid compounds in respiratory pathologies
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.9. Usefulness of the use of cannabinoids in traumatology
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.10. Effects of cannabinoids on bone tissue
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.11. Potential therapeutic utility of cannabinoid compounds in genitourinary disorders
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.12. Therapeutic potential of the use of cannabinoid compounds in the treatment of ophthalmologic pathologies
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.13. Cannabinoids in dermatology
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Section 5. Patents and cannabinoid research seminar
Patent Seminar. Patents related to cannabinoid compounds
Prof. Ramón Soto, National Autonomous University of Mexico, Mexico
Research Seminar. Genetically modified mice in neuropsychopharmacology research
Prof. Jan Rodríguez Parkitna, Maj Institute of Pharmacology Polish Academy of Sciences, Poland
Course Schedule
Sections 0 and 1: start 4th December 23
Section 2: Start 22nd January 24
Section 3: Start 18th March 24
Section 4: Start 13th May 24
Section 5: Start 1st July 24
CERTIFICATION
The contents taught in the form of knowledge pills (audiovisual) will be evaluated after each thematic block (clinical case, discussion forum and a questionnaire).
To access the content you must be registered for the course (free of charge at http://www.specalistcannabinoids.umh/).
Passing these evaluations will entitle the student to the Director’s Certification of the course, equivalent to 75 hours.